Magnetic resonance imaging for staging cervical and endometrial cancer

Medical Services Advisory Committee
Record ID 32002000525
Authors' objectives:

This report aims to assess the effectiveness of magnetic resonance imaging (MRI) for staging cervical and endometrial cancer.

Authors' recommendations: MSAC recommends on the strength of evidence pertaining to Magnetic Resonance Imaging (MRI) for staging of cervical and endometrial cancer that: 1. Public funding should be supported for MRI staging of histologically proven cervical cancer at FIGO stages IB or greater following assessment by examination under anaesthesia; 2. At present there is insufficient evidence to support public funding for MRI in patients with recurrent cervical cancer but further studies may require this issue to be reviewed in the future; and 3. Public funding should not be supported for MRI staging of endometrial cancer at this time.
Authors' methods: Systematic review
Project Status: Completed
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Magnetic Resonance Imaging
  • Neoplasm Staging
  • Endometrial Neoplasms
  • Uterine Cervical Neoplasms
Organisation Name: Medical Services Advisory Committee
Contact Address: MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
Contact Email:
Copyright: Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.